Blood pressure (BP) reduction of 5-6 mm Hg reduces the relative risk of stroke by 30-40%. This effect does not appear to depend on the antihypertensive agent used to bring about the required reduction in BP. Patients with acute ischaemic stroke often exhibit an elevated BP. These patients, who previously suffered from hypertension, have significantly higher levels of BP readings on admission with increased incidence of stroke immediately after arising. The aim of this study was to compare antihypertensive agents, especially short and long acting drugs with the measurement of BP on admission, the time of the ischaemic stroke and its clinical severity. This was studied retrospectively in 109 patients (55 females and 54 males). The mean age
Introduction
Hypertension is associated with haemorrhagic stroke but is also a main risk factor for ischaemic stroke and is found in 75% of these cases. 1 The relationship that exists between diastolic blood pressure (DBP) and stroke is significant although systolic blood pressure (SBP) correlates more strongly. 2, 3 The experimental studies on focal cerebral ischaemia demonstrate that around the core of densely ischaemic tissue is a rim of ischaemic but viable tissue, the so-called ischaemic penumbra. This rim of tissue varies in volume according to the presence of a collateral blood supply and probably represents a dynamic situation. Autoregulation normally maintains cerebral blood flow in the face of a decline in systemic arterial pressure, by vasodilatation. After stroke, blood vessels within this region are maximally dilated and cerebral blood flow was 69.7 ؎ 10.4 years. All the patients admitted between 1 July 1996 and 30 June 1997 for ischaemic stroke as established by brain CT scan, were studied. Of the stroke subjects not treated or treated with short acting calcium blockers, 40.8% and 44.4% of them respectively appeared to have an ischaemic stroke in the early morning hours in contrast to 20% of those treated with long acting calcium blockers (P Ͻ 0.05). The last group of patients also experienced less clinical severity.
These results emphasise the need for proper 24-h control of BP and by comparison to other antihypertensive agents, the long acting calcium blockers with these subjects may prevent a sudden early morning rise in BP, which is instrumental in stroke prevention.
becomes proportional to systemic arterial pressure. Even a small change in blood pressure (BP) may shift the balance between viability and cell death within parts of this penumbra. In experimental models of stroke, BP is normally maintained at a constant level and, if it is not, the size of the resulting infarct and the haemorrhagic transformation dependent on BP. 4 Thus, too high a BP correlates with more haemorrhagic transformations and too low a BP correlates with neurological deterioration. Control of BP over the full 24-h period is important in reducing the incidence of ischaemic stroke. 5, 6 The greatest incidence of sudden death, acute myocardial infarction and ischaemic stroke [7] [8] [9] is associated with BP increases that occur on awakening and arising. It was seen that once-daily therapy with pharmacological agents shorter than 24-h effectiveness for hypertension saw the advent of problems created by the large drop in blood concentration of drugs and the resultant rise in BP before the next dose. Morgan and Anderson 10 suggest that the answer is to use drugs with an elimination half-life close to or greater than the dose interval of 24 h. The alternative is to give drugs more frequently than once a day, which results in a reduction in patient compliance. Numerous studies have shown that effective control of elevated BP has greatly reduced the risk of ischaemic stroke. 11 The optimal management of BP in patients in the early phase of ischaemic stroke is unknown and clinical practice varies accordingly. Management guidelines that have been proposed including JNC VI recommendations have been based on consensus statements rather than controlled trial evidence, and recommended treatment only for severe (180-220/110-120 mm Hg on repeated measurements) or complicated hypertension (cardiac failure or arterial dissection) after acute stroke. [12] [13] [14] [15] [16] The strikingly lower rate of haemorrhagic transformation within the National Institute of Neurological Disorders and Stroke rt-PA study 17 may be related to the exclusion of patients with uncontrolled hypertension, reinforcing the theoretical view that haemorrhagic transformation or cerebral oedema may be exacerbated by hypertension. This provides some rationale for BP control in the early hours or days after stroke which, taken with the evidence favouring long-term BP control, suggests that there may be an optimal time and degree of BP reduction that has yet to be established. This leads to the speculation that those patients who were admitted without fluctuating BP and had stable average BP do not need intervention and could have a better prognosis.
The aim of this retrospective study was to compare the prior antihypertensive agents, especially short and long acting drugs, with the admission of BP measurements, the time of the event and its clinical severity.
Materials and methods
In this retrospective study we studied the effects of prior pharmacological treatment of all hypertensive patients hospitalised in Barzilai Medical Center in Ashkelon, Israel, for ischaemic stroke throughout 1 year from 1 July 1996 to 30 June 1997. All data were collected from patient's hospital files according to the ICD-9 codes. CT scan verified ischaemic stroke, which was proved by a so-called normal CT scan and was taken 1 to 3 days after admission. The following parameters were measured: the first admission BP, heart rate (HR), clinical severity (hemiplegia vs hemiparesis) and outcome (death, discharge), event and admission time. The differences of these parameters between short and long acting drugs, combinations of short acting drugs, and no treatment were examined.
All BP taken into account are the first readings taken by the triage nurse, on admission. The admitting physician took the medical history, the neurological status and the physical examination. Statistical analysis was by means of the one-way ANOVA test and was used to test the hypothesis of no difference between the antihypertensive agent groups. The classification (and abbreviations used) of drugs as was done according to the main antihypertensive groups as follows: Non = not treated 3 days or more prior to the ischaemic stroke; S-ACEi = short acting ACE inhibitor; O-COMB = others and/or combinations of short acting drugs; L-CAB = long acting calcium blockers; S-CAB = short acting calcium blockers; SBP = systolic blood pressure; DBP = diastolic blood pressure; HR = heart rate, *P Ͻ 0.05.
Results
A total of 109 hypertensive patients admitted with ICD-9 code of ischaemic stroke during the year from 1 July 1996 and 30 June 1997. There were 55 females and 54 males with a mean age of 69.7 ± 10.4 years (45-96 years). The prevalence of risk factors for stroke were: diabetes mellitus n = 47 (43%), left ventricular hypertrophy (ECG criteria) n = 46 (42%), smoking n = 36 (33%), dyslipidaemia n = 29 (26%), atrial fibrillation n = 14 (13%), and ischaemic heart disease n = 5 (4.6%). Table 1 shows that on admission a statistically significant number of patients (39 (35.7%)) were not receiving treatment. That group had the greatest number of subjects suffering from hemiplegia (four from 39 cases), long acting calcium antagonists had better control on admission systolic BP, diastolic BP and heart rate. That group also had a much smaller incidence of hemiplegia and death (one from 15 cases respectively) and a lower incidence of events in the dangerous hours (three from 15 cases = 20%). Occurrence of events (Figure 1 ) varied according to the time of year, being highest in January which was also the coldest month in Israel in 1997; and day being highest on Thursday (Figure 2) . Occurrences of events seem to relate to the time of day ( Figure  3 ). The greatest number of events occurring in the early morning between 6 to 8 am. This seems to correlate to the peak admission time (Figure 4 
Discussion and conclusions
It is well known that patients with an acute ischaemic stroke often exhibit an elevated BP. Patients suffering previously from hypertension have significantly higher levels on admission. 18 Prior treatment of these patient's hypertension can save many of them from stroke (haemorrhagic and ischaemic), with no evidence that any one treatment modality is any more or less effective in reducing stroke incidence. 3 In our study (Table 1) , we see that a significant number of patients received no treatment for hypertension on admission to hospital (35.7%). Judging by that number, more vigorous education by health professionals for hypertensive patients is indicated. Facilitation of drug therapy in the form of reliable once-a-day dosage is strongly recommended.
A so-called normal CT scan is defined as one where no bleeding occurs and is proved by that criterion. The results in Table 1 show that treated patients had a better prognosis for survival. There was a 30-40% reduction in relative onset of ischaemic stroke in the high risk hours. There was also a time lag of 3 h between the occurrence of an *P Ͻ 0.01. SBP, systolic BP; DBP, diastolic BP; HR, heart rate; none, not treated, or stopped treatment 3 days before stroke; L-CAB, long acting calcium antagonists (niphedipine GITS, amlodipine, felodipine); S-CAB, short acting calcium antagonists (niphedipine, dilthiazem); S-ACEi, short acting angiotensin-converting enzyme inhibitors (captopril); O-COMB, others and combination therapies (thiazides, propanolol, atenolol, enalapril, prazosin). The last group was not divided in subgroups due to small numbers.
Figure 1
The occurrence of ischaemic stroke events: a monthly distribution.
ischaemic stroke and subsequent admission to hospital of the patient. This lag could be explained partly by transportation delays and by a lack of awareness by patients for the immediate need for diagnosis of the cause of stroke (ischaemic vs haemorrhagic) and thus the appropriate treatment to institute. In this study, the greatest number of occurrences of ischaemic stroke was in the morning hours between 6 and 8 am, and it was also noted that of the untreated patients or those treated with S-CAB, approximately half of them suffered a stroke at those times. This is in strong contrast to subjects being treated with long acting calcium blockers where only 20% were affected during early morning hours (P Ͻ 0.05). It is possible that L-CAB may prevent a sudden early morning rise in BP.
This data reinforces the argument that the optimal formulation for once-a-day dosage regimen should provide a 24-h efficacy with at least 50% of the peak effect remaining at the end of the dosage period.
Advantages of the use of long acting medication are many: (1) drug compliance is better with fewer daily doses; (2) sometimes fewer tablets means a lower cost; (3) control of hypertension is more constant and smoother, rather than intermittent; and controlled hypertension on admission may reduce haemorrhagic transformation and thus may improve prognosis. 17 This knowledge is advocated including education of health professionals and lay persons. 19 We know that calcium blockers (and in particular long acting drugs in that group) prevent an early morning rise in BP, which prevents strokes. Also the patients being admitted are less seriously ill. There was no mortality in that group. This could be due to the further benefits of the dihydropyridine calcium antagonist in addition to those related to BP reduction; as these agents block the influx of calcium into ischaemic brain cells, thereby limiting the extent of the infarction. 20 However, although these effects have been impressive in experimental models there is as yet no concrete evidence of this effect in clinical studies. It is also interesting to note that the coldest month was the most dangerous one and that Thursday, which is the last working day in Israel, was also the most eventful, with patients being the most tired at that time. This is different to Europe, where Monday is the most dangerous day of the week probably because of the high consumption of alcoholic beverages at the weekend. Further research may reveal the true relationship between time and day of the week and month of the year, and therefore the training of patients and medical personnel could be geared to deal with the events happening on those critical days. Good control of BP with self-measurement 21 and ambulatory automatic BP monitoring 22 are increasingly important to ensure the 24-h duration of action of antihypertensive agents. This is particularly critical with the increasing use of once-a-day medications that often do not provide 24-h efficacy. 23, 24 Thereby, the patient is exposed to the full impact of the early morning abrupt rise in pressure that is almost certainly involved in the increased incidence of various cardiovascular events immediately after arising.
Caution is advised against having patients take their medication late in the evening or before retiring, since virtually every formulation has its maximal effect within 3 to 4 h and, BP usually falls considerably for the first 5 to 6 h of sleep. Hypotension and tissue ischaemia could thereby be induced. 25 In the future, formulations may become available that release the medication only after a 4 to 6-h interval, so bed-time dosing would be appropriate.
